10794 related articles for article (PubMed ID: 10972550)
21. Proton magnetic resonance spectroscopy of brain tumors correlated with pathology.
Magalhaes A; Godfrey W; Shen Y; Hu J; Smith W
Acad Radiol; 2005 Jan; 12(1):51-7. PubMed ID: 15691725
[TBL] [Abstract][Full Text] [Related]
22. Nuclear magnetic resonance studies on human bone and soft tissue tumors.
Mizuta H; Yamasaki M
Nihon Seikeigeka Gakkai Zasshi; 1984 Jan; 58(1):97-106. PubMed ID: 6747405
[TBL] [Abstract][Full Text] [Related]
23. Malignant soft-tissue tumors in a large referral population: distribution of diagnoses by age, sex, and location.
Kransdorf MJ
AJR Am J Roentgenol; 1995 Jan; 164(1):129-34. PubMed ID: 7998525
[TBL] [Abstract][Full Text] [Related]
24. Lipids in bone tumors assessed by magnetic resonance: chemical shift imaging and proton spectroscopy in vivo.
Schick F; Duda SH; Lutz O; Claussen CD
Anticancer Res; 1996; 16(3B):1569-74. PubMed ID: 8694528
[TBL] [Abstract][Full Text] [Related]
25. Spectroscopic and perfusion magnetic resonance imaging predictors of progression in pediatric brain tumors.
Tzika AA; Astrakas LG; Zarifi MK; Zurakowski D; Poussaint TY; Goumnerova L; Tarbell NJ; Black PM
Cancer; 2004 Mar; 100(6):1246-56. PubMed ID: 15022293
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathological, immunohistochemical, and ultrastructural study of 13 cases of melanotic schwannoma.
Zhang HY; Yang GH; Chen HJ; Wei B; Ke Q; Guo H; Ye L; Bu H; Yang K; Zhang YH
Chin Med J (Engl); 2005 Sep; 118(17):1451-61. PubMed ID: 16157048
[TBL] [Abstract][Full Text] [Related]
27. N-acetyl resonances in in vivo and in vitro NMR spectroscopy of cystic ovarian tumors.
Kolwijck E; Engelke UF; van der Graaf M; Heerschap A; Blom HJ; Hadfoune M; Buurman WA; Massuger LF; Wevers RA
NMR Biomed; 2009 Dec; 22(10):1093-9. PubMed ID: 19593761
[TBL] [Abstract][Full Text] [Related]
28. In vivo quantification of the metabolites in normal brain and brain tumors by proton MR spectroscopy using water as an internal standard.
Tong Z; Yamaki T; Harada K; Houkin K
Magn Reson Imaging; 2004 Sep; 22(7):1017-24. PubMed ID: 15288143
[TBL] [Abstract][Full Text] [Related]
29. The use of magnetic resonance imaging in the evaluation of bone and soft-tissue tumors.
Dalinka MK; Zlatkin MB; Chao P; Kricun ME; Kressel HY
Radiol Clin North Am; 1990 Mar; 28(2):461-70. PubMed ID: 2408105
[TBL] [Abstract][Full Text] [Related]
30. Metastases to soft tissue: a review of 118 cases over a 30-year period.
Plaza JA; Perez-Montiel D; Mayerson J; Morrison C; Suster S
Cancer; 2008 Jan; 112(1):193-203. PubMed ID: 18040999
[TBL] [Abstract][Full Text] [Related]
31. [Soft tissue malignancies in childhood and adolescence. Pathology and clinical relevance based on data from the kiel pediatric tumor registry].
Harms D
Handchir Mikrochir Plast Chir; 2004 Oct; 36(5):268-74. PubMed ID: 15503256
[TBL] [Abstract][Full Text] [Related]
32. [Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors].
Lichy MP; Bachert P; Hamprecht F; Weber MA; Debus J; Schulz-Ertner D; Schlemmer HP; Kauczor HU
Rofo; 2006 Jun; 178(6):627-33. PubMed ID: 16703499
[TBL] [Abstract][Full Text] [Related]
33. Molecular characterization of musculoskeletal tumors by proton MR spectroscopy.
Fayad LM; Barker PB; Bluemke DA
Semin Musculoskelet Radiol; 2007 Sep; 11(3):240-5. PubMed ID: 18260034
[TBL] [Abstract][Full Text] [Related]
34. [Tumors of the hand].
Grünert J; Büchler U
Ther Umsch; 1995 Jan; 52(1):66-74. PubMed ID: 7855752
[TBL] [Abstract][Full Text] [Related]
35. Visceral primitive peripheral neuroectodermal tumors: a clinicopathologic and molecular study.
O'Sullivan MJ; Perlman EJ; Furman J; Humphrey PA; Dehner LP; Pfeifer JD
Hum Pathol; 2001 Oct; 32(10):1109-15. PubMed ID: 11679946
[TBL] [Abstract][Full Text] [Related]
36. [Fluid-fluid levels in bone and soft tissue tumors demonstrated by MR imaging].
Sone M; Ehara S; Sasaki M; Nakasato T; Tamakawa Y; Shiraishi H; Abe M
Nihon Igaku Hoshasen Gakkai Zasshi; 1992 Aug; 52(8):1110-5. PubMed ID: 1408681
[TBL] [Abstract][Full Text] [Related]
37. Pre-operative radiotherapy in soft tissue tumors. Assessment of response by static post-contrast MR imaging compared to histopathology.
Einarsdottir H; Wejde J; Bauer HC
Acta Radiol; 2001 Jan; 42(1):1-5. PubMed ID: 11167322
[TBL] [Abstract][Full Text] [Related]
38. [Oral-maxillofacial malignant tumors: an initial study with in vivo single-voxel 1H MR spectroscopy].
Yu Q; Wang PZ; Shi HM; Luo JC
Zhonghua Kou Qiang Yi Xue Za Zhi; 2007 Jan; 42(1):18-20. PubMed ID: 17331436
[TBL] [Abstract][Full Text] [Related]
39. Prevalence and diagnostic significance of fluid-fluid levels in soft-tissue neoplasms.
Alyas F; Lee J; Ahmed M; Connell D; Saifuddin A
Clin Radiol; 2007 Aug; 62(8):769-74; discussion 775. PubMed ID: 17604765
[TBL] [Abstract][Full Text] [Related]
40. [Usefulness of diffusion-weighted MRI in differentiating benign from malignant musculoskeletal tumors].
Nagata S; Nishimura H; Uchida M; Hayabuchi N
Nihon Igaku Hoshasen Gakkai Zasshi; 2005 Jan; 65(1):30-6. PubMed ID: 15726897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
